Strong Performance Of Novartis Pharmaceutical Company Paves Way For Continued Growth

Researched by Industrial Info Resources -- Multinational pharmaceutical company Novartis AG (Basel, Switzerland) showed strong global financial growth for the second half of 2008, despite sales declines in the U.S. market. Novartis is involved in the research, manufacturing and distribution of both patented and generic medicines for humans and animals, vaccines, diagnostic equipment and other health-related products. Overall, for the first half of 2008, the company showed a global net sales increase of 11%, reaching about $20.6B. Net sales in most countries were up, although compared with the first half of 2007, the U.S., which had net sales of about $6.2B, showed an 8% drop.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at www.industrialinfo.com/showNews.jsp?newsitemID=138237, or browse other breaking industrial news stories at www.industrialinfo.com.

About Industrial Info Resources
Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. For more information visit us at www.industrialinfo.com.

SOURCE: Industrial Info Resources